Link Pharma Chem Ltd. (LINKPH.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-239.8%

-₹36.36

vs ₹26.00 price

Levered DCF

₹201.23

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

—

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	133.29×	-14.64×	-14.22×	24.9×	9.49×	9.69×	7.97×	16.62×
P/B	0.8×	1.19×	1.41×	1.08×	1.23×	0.84×	0.66×	1.05×
P/S	0.37×	0.59×	0.65×	0.42×	0.33×	0.3×	0.3×	0.45×
EV / EBITDA	10.29×	65.72×	-3,003.76×	9.7×	6×	3.32×	3.39×	6.13×
Gross margin	23.2%	13.5%	2.0%	40.1%	28.5%	42.8%	52.7%	46.9%
Operating margin	1.7%	-3.2%	-5.6%	4.6%	4.8%	6.5%	9.8%	4.7%
Net margin	0.3%	-4.0%	-4.6%	1.7%	3.5%	3.1%	3.7%	2.7%
Current ratio	1.01×	1.11×	1.05×	1.21×	1.28×	1.63×	2.63×	1.47×
Debt / equity	0.57×	0.46×	0.67×	0.58×	0.44×	0.29×	0.31×	0.25×
Interest coverage	0.87×	-1.05×	-1.93×	2.36×	5.7×	5.14×	6.88×	2.99×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	0.6%	-8.1%	-9.9%	4.3%	13.0%	8.6%	8.3%	6.3%
Return on invested capital	1.3%	-3.2%	-5.2%	5.4%	8.5%	8.5%	10.3%	5.8%
Return on assets	0.3%	-4.4%	-5.3%	2.0%	6.5%	4.2%	5.0%	3.7%
Free cash flow yield	-4.3%	13.1%	-5.0%	-16.0%	-13.5%	28.9%	16.4%	4.4%
Earnings yield	0.8%	-6.8%	-7.0%	4.0%	10.5%	10.3%	12.5%	6.0%
Enterprise value	₹169.2M	₹207.5M	₹285.4M	₹249.2M	₹239.9M	₹99.4M	₹92.6M	₹135.4M
Net debt / EBITDA	4.06×	18.11×	-963.97×	3.37×	1.53×	-0.19×	0.62×	1.18×
Cash conversion cycle (days)	101	110	119	90	3	-79	31	33